Anshul Shakya

An <i>in-silico</i> evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets

Saurabh K. Sinha, Anshul Shakya, Satyendra K. Prasad et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 187 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Identification of bioactive compounds from <i>Glycyrrhiza glabra</i> as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study

Saurabh K. Sinha, Satyendra K. Prasad, Md Ataul Islam et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 130 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10

Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an <i>in-silico</i> approach

Rupesh V. Chikhale, Shailendra Gurav, Rajesh B. Patil et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 121 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

<i>In-silico</i> investigation of phytochemicals from <i>Asparagus racemosus</i> as plausible antiviral agent in COVID-19

Rupesh V. Chikhale, Saurabh K. Sinha, Rajesh B. Patil et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 88 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16

Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4‐aminoquinoline‐1,3,5‐triazine derivatives

Hans Raj Bhat, Anup Masih, Anshul Shakya et al. · Journal of Heterocyclic Chemistry · 2019 · 67 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16